Abstract
Patients with Parkinson disease exhibit a highly increased prevalence of small intestinal bacterial overgrowth (SIBO), which has been also associated with the severity of motor fluctuations. Aim of this study was to test the efficacy of liquid levodopa with higher bioavailability in patients with SIBO.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 91-95 |
| Numero di pagine | 5 |
| Rivista | Clinical Neuropharmacology |
| Volume | 37 |
| Numero di pubblicazione | 4 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2014 |
All Science Journal Classification (ASJC) codes
- Farmacologia
- Neurologia (clinica)
- Farmacologia (medica)
Keywords
- bacterial overgrowth
- liquid melevodopa
Fingerprint
Entra nei temi di ricerca di 'Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver